Notice Number: NOT-NS-17-014
Key Dates
Release Date: February 6, 2017
Issued by
National Institute of Neurological Disorders and Stroke (NINDS)
Purpose
The purpose of this Notice is to inform interested applicants that the expiration date for the Funding Opportunity Announcement (FOA) PAR-14-289 "NINDS CREATE Bio Development Track: Preclinical and Early-phase Clinical Development for Biotechnology Products and Biologics (U44)" will be extended by one receipt cycle. An additional non-AIDS application due date of July 18, 2017, and AIDS and AIDS-related applications due date on September 7, 2017 has been added for this FOA This FOA expires on September 8, 2017.
The Key Dates table is updated accordingly:
Application Due Date(s) |
October 21, 2014; February 11, 2015; August 11, 2015; February 11, 2016; August 11, 2016; February 8, 2017; July 18, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
AIDS Application Due Date(s) |
January 7, 2015; May 7, 2015; September 7, 2015; May 7, 2016; September 7, 2016; and May 7, 2017; September 7, 2017, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
Scientific Merit Review |
February 2015; June 2015; November 2015; June 2016; November 2016; June 2017; November 2017 |
Advisory Council Review |
May 2015; October 2015; January 2016; October 2016; January 2017; October 2017; January 2018 |
Earliest Start Date(s) |
July 2015 |
Expiration Date |
September 8, 2017 |
All other aspects of the FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Chris Boshoff, Ph.D.,
National Institute of Neurological Disorders and Stroke (NINDS)
Telephone: 301-496-1779
Email: [email protected]